Blog

Paolo Tarantino: Proud to be part of the Italian winners of the ASCO Conquer Merit Award 2025

Paolo Tarantino/X

Jun 2, 2025, 13:00

Paolo Tarantino: Proud to be part of the Italian winners of the ASCO Conquer Merit Award 2025

Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post on LinkedIn:

“Proud to be part of the Italian winners of the ASCO Conquer Merit Award 2025!

The papers I will present at this year’s congress exemplify my scientific mission:

Develop new conjugated antibodies to improve the prognosis of breast cancer patients.
Validate biomarkers that allow personalization of antibody conjugate therapies.
Identify subgroups of patients for whom “less is more” — i.e. chemotherapy can be omitted without risk.

A long and tortuous path, made possible by multiple mentors, the funds donated for research and the courageous patients who participate in our research.

Thank you Conquer Cancer, the ASCO Foundation for the award and thank you Irma D’Aria and La Repubblica for the mention. Link.”

“The numbers: 6/16 trained in the Oncology Specialization School of the University of Milan – State University!”

Paolo Tarantino: Proud to be part of the Italian winners of the ASCO Conquer Merit Award 2025

More posts featuring Paolo Tarantino.

ASCO ASCO Conquer Merit Award Breast Cancer cancer Conjugate Therapy Conquer Cancer Dana-Farber Cancer Institute fight against cancer Giuseppe Curigliano Global fight against cancer Harvard Medical School Irma D'Aria la Repubblica OncoDaily Oncology Paolo Tarantino University of Milan uropean Institute of Oncology

Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

15 Posts Not to Miss from EACR 2025

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine